Insider · CIK 0001491072
Anson Funds Management LP
Files at LITS (MEI Pharma, Inc.), TRLH (Trilogy International Partners Inc.). First filing Feb 26, 2024, latest Feb 26, 2024.
In brief
Anson Funds Management LP files SEC Form 4 as 10% owner at TRLH (Trilogy International Partners Inc.), and also at LITS (MEI Pharma, Inc.). Since Feb 26, 2024, Anson Funds Management LP has reported 0 open-market buys worth $0 and 1 open-market sell worth $30k, the latest filed on Feb 26, 2024.
A track record needs three past buys with six months of prices behind them; Anson Funds Management LP has 0, so none is measured yet.
The newest scored trade: sold $30k of TRLH on Nov 14, 2023, filed Feb 26, 2024, scored 17 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | TRLHsell Trilogy International Partners Inc. | $30k 473,000 shares | -5% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 28, 2025 | LITS MEI Pharma, Inc. | 1,093,184 3.66% of outstanding | $7.4M | Jul 28, 2025 | none |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | TRLH Trilogy International Partners Inc. | SOpen-market sale Common Shares, no par valueindirect: See footnotes | -211,000 | $0.06 | $12k | 9,242,250 | Feb 26, 2024 |
| Nov 15, 2023 | TRLH Trilogy International Partners Inc. | SOpen-market sale Common Shares, no par valueindirect: See footnotes | -75,000 | $0.06 | $4,125 | 9,167,250 | Feb 26, 2024 |
| Dec 18, 2023 | TRLH Trilogy International Partners Inc. | SOpen-market sale Common Shares, no par valueindirect: See footnotes | -87,000 | $0.07 | $6,090 | 9,080,250 | Feb 26, 2024 |
| Dec 20, 2023 | TRLH Trilogy International Partners Inc. | SOpen-market sale Common Shares, no par valueindirect: See footnotes | -100,000 | $0.08 | $8,000 | 8,980,250 | Feb 26, 2024 |
| Oct 20, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Common Stockindirect: See footnotes | +143,200 | $7.00 | $1.0M | 1,057,388 | Oct 24, 2023 |
| Oct 20, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Common Stockindirect: See footnotes | +35,800 | $7.00 | $251k | 1,093,188 | Oct 24, 2023 |
| Oct 20, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Put Option (obligation to buy)derivativeindirect: See footnotes | -1,432 | $0.00 | $0 | 7,068 | Oct 24, 2023 |
| Oct 20, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Put Option (obligation to buy)derivativeindirect: See footnotes | -358 | $0.00 | $0 | 6,710 | Oct 24, 2023 |
| Oct 20, 2023 | LITS MEI Pharma, Inc. | EExpiration of short derivative Put Option (obligation to buy)derivativeindirect: See footnotes | -6,710 | $0.00 | $0 | 0 | Oct 24, 2023 |
| Oct 11, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Common Stockindirect: See footnotes | +40,000 | $7.00 | $280k | 904,188 | Oct 13, 2023 |
| Oct 11, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Common Stockindirect: See footnotes | +10,000 | $7.00 | $70k | 914,188 | Oct 13, 2023 |
| Oct 11, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Put Option (obligation to buy)derivativeindirect: See footnotes | -400 | $0.00 | $0 | 8,600 | Oct 13, 2023 |
| Oct 11, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Put Option (obligation to buy)derivativeindirect: See footnotes | -100 | $0.00 | $0 | 8,500 | Oct 13, 2023 |
Questions about Anson Funds Management LP
Answered from the filings on this page, as of the latest one.
Is Anson Funds Management LP buying or selling?
Not in the last 12 months. Anson Funds Management LP's latest open-market trade on SEC Form 4 was sold $30k of TRLH on Nov 14, 2023.
How did Anson Funds Management LP's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anson Funds Management LP has 0.
Where does Anson Funds Management LP file Form 4?
Anson Funds Management LP has filed Form 4 at TRLH (Trilogy International Partners Inc.); LITS (MEI Pharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.